These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 9307605
1. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605 [Abstract] [Full Text] [Related]
2. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC, Kilbourn MR, Kuhl DE. J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703 [Abstract] [Full Text] [Related]
4. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies. Kilbourn MR, Sherman PS, Kuszpit K. Synapse; 2002 Mar 01; 43(3):188-94. PubMed ID: 11793424 [Abstract] [Full Text] [Related]
10. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain. Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Exp Neurol; 2004 Aug 01; 188(2):387-90. PubMed ID: 15246838 [Abstract] [Full Text] [Related]
12. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. Chan GL, Holden JE, Stoessl AJ, Samii A, Doudet DJ, Dobko T, Morrison KS, Adam M, Schulzer M, Calne DB, Ruth TJ. J Nucl Med; 1999 Feb 01; 40(2):283-9. PubMed ID: 10025836 [Abstract] [Full Text] [Related]
14. In vivo measurement of the vesicular monoamine transporter in schizophrenia. Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA. Neuropsychopharmacology; 2000 Dec 01; 23(6):667-75. PubMed ID: 11063922 [Abstract] [Full Text] [Related]